Benzbromarone (INN) is a uricosuric agent and non-competitive inhibitor of xanthine oxidase used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. It is structurally related to the antiarrhythmic amiodarone.
Benzbromarone is highly effective and well tolerated, and clinical trials as early as 1981 and as recently as April 2008 have suggested it is superior to both allopurinol, a xanthine oxidase inhibitor but not uricosuric, and probenecid, another uricosuric drug.

0

Hebei yanxi chemical co., ltd is a professional research and development of the production of lead acetate, 2-phenylethylamide enterprises.under the innovation in traditional production equipment and technology, the use of "high temperature cooling" and "plastic basin crystallization" technology, on the basis of reducing the cost of products to make the quality of products to the same industry. Under the close supervision of the quality inspection department of the company, we carry out production and sales in the way of "labeling", providing the most convenient and fastest service for users all over the world.

Any inquiries, pls feele to contact us!